Parafibromin expression is an independent prognostic factor for colorectal carcinomas

Human Pathology

Volumn 42, Issue 8, 2011, Pages 1089-1102

  Zheng, Hua Chuan ^a   Wei, Zheng Li ^a   Xu, Xiao Yan ^a   Nie, Xiao Cui ^a   Yang, Xue ^a   Takahashi, Hiroyuki ^b   Takano, Yasuo ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Colorectal carcinoma; Parafibromin; Pathogenesis; Prognosis; Progression

Indexed keywords

ALKALINE PHOSPHATASE; BECLIN 1; BETA ACTIN; BETA CATENIN; CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN E; MESSENGER RNA; MYC PROTEIN; ONCOPROTEIN; PARAFIBROMIN; PROTEIN BAX; PROTEIN P21; PROTEIN P27; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MIGRATION; CELL NUCLEUS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PLASMID; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 79960394757     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.10.024     Document Type: Article

References (33)

1. American Cancer Society. Colorectal cancer facts and figures 2008-2010 Atlanta: American Cancer Society 2008 edition
2. Yoshida D., Kono S., and Moore M.A. Colorectal polypectomy and risk of colorectal cancer by subsite: the Fukuoka Colorectal Cancer study Jpn J Clin Oncol 37 2007 597 602 (Pubitemid 351790803)
3. Aldred M.J., Talacko A.A., and Savarirayan R. Dental findings in a family with hyperparathyroidism-jaw tumour syndrome and a novel HRPT2 gene mutation Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 2006 212 218 (Pubitemid 43163223)
4. Pimenta F.J., Gontijo Silveira L.F., and Tavares G.C. HRPT2 gene alterations in ossifying fibroma of the jaws Oral Oncol 42 2006 735 739 (Pubitemid 44094240)
5. Shattuck T.M., Välimäki S., and Obara T. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma N Engl J Med 349 2003 1722 1729 (Pubitemid 37315009)
6. Bradley K.J., Cavaco B.M., Bowl M.R., Harding B., Young A., and Thakker R.V. Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism J Med Genet e51 2005 42
7. Carpten J.D., Robbins C.M., and Villablanca A. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumour syndrome Nat Genet 32 2002 676 680 (Pubitemid 35435184)
8. Wang P.F., Tan M.H., Zhang C., Morreau H., and Teh B.T. HRPT2, a tumour suppressor gene for hyperparathyroidism-jaw tumour syndrome Horm Metab Res 37 2005 380 383 (Pubitemid 41008773)
9. Krogan N.J., Dover J., and Wood A. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation Mol Cell 11 2003 721 729 (Pubitemid 36385125)
10. Porzionato A., Macchi V., and Barzon L. Immunohistochemical assessment of parafibromin in mouse and human tissues J Anat 209 2006 7
11. Rozenblatt-Rosen O., Hughes C.M., and Nannepaga S.J. The parafibromin tumour suppressor protein is part of a human Paf1 complex Mol Cell Biol 25 2005 612 620 (Pubitemid 40096583)
12. Wood A., Krogan N.J., and Dover J. Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter Mol Cell 11 2003 267 274 (Pubitemid 36126607)
13. Yart A., Gstaiger M., and Wirbelauer C. The HRPT2 tumour suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II Mol Cell Biol 25 2007 5052 5060 (Pubitemid 40781105)
14. Zhang C., Kong D., and Tan M.H. Parafibromin inhibits cancer cell growth and causes G1 phase arrest Biochem Biophys Res Commun 350 2006 17 24 (Pubitemid 44466569)
15. Yang Y.J., Han J.W., Youn H.D., and Cho E.J. The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression Nucleic Acids Res 38 2010 382 390
16. Lin L., Zhang J.H., Panicker L.M., and Simonds WF The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene Proc Natl Acad Sci U S A 105 2008 17420 17425
17. Vaqué J.P., Fernández-García B., and García-Sanz P. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation Mol Cancer Res 6 2008 325 339 (Pubitemid 351342420)
18. Zhang Z., Zeng B., and Jiao G. AA28-67 domain within MyD88 suppresses c-myc activity and expression to regulate differentiation and function of dendritic cells Clin Immunol 133 2009 324 332
19. Alfano D., Votta G., and Schulze A. Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor Mol Cell Biol 30 2010 1838 1851
20. Chuan Y.C., Iglesias-Gato D., and Fernandez-Perez L. Ezrin mediates c-Myc actions in prostate cancer cell invasion Oncogene 29 2010 1531 1542
21. Howell V.M., Haven C.J., and Kahnoski K. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours J Med Genet 40 2003 657 663 (Pubitemid 37100697)
22. Newey P.J., Bowl M.R., Cranston T., and Thakker R.V. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors Hum Mutat 31 2010 295 307
23. Gill A.J., Clarkson A., and Gimm O. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumour (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias Am J Surg Pathol 30 2006 1140 1149 (Pubitemid 44299347)
24. Hahn M.A., Howell V.M., and Gill A.J. CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors Endocr Relat Cancer 17 2010 273 282
25. Selvarajan S., Sii L.H., and Lee A. Parafibromin expression in breast cancer: a novel marker for prognostication? J Clin Pathol 61 2008 64 67 (Pubitemid 351158227)
26. Zheng H.C., Takahashi H., and Li X.H. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas Virchows Arch 452 2008 147 155
27. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumours 6th ed. 2000 John Wiley & Sons, Hoboken New Jersey, USA
28. Hamilton S.R., and Aaltonen L.A. WHO classification of tumors: pathology and genetics of tumors of the digestive system 2000 IARC press Lyon
29. Kumada T., Tsuneyama K., Hatta H., Ishizawa S., and Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 2004 1141 1149 (Pubitemid 39128241)
30. Zheng H.C., Nakamura T., and Zheng Y. SV40 T antigen disrupted the cell metabolism and the balance between proliferation and apoptosis in lens tumors of transgenic mice J Cancer Res Clin Oncol 135 2009 1521 1532
31. Pajalunga D., Mazzola A., Franchitto A., Puggioni E., and Crescenzi M. The logic and regulation of cell cycle exit and reentry Cell Mol Life Sci 65 2008 8 15
32. Müller G.A., and Engeland K. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription FEBS J 277 2010 877 893
33. Perdiguero E., and Nebreda A.R. Regulation of Cdc25C activity during the meiotic G2/M transition Cell Cycle 3 2004 733 737 (Pubitemid 40187901)